These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 23271494

  • 1. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
    Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
    Eur J Pediatr; 2013 Apr; 172(4):513-8. PubMed ID: 23271494
    [Abstract] [Full Text] [Related]

  • 2. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Apr; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 3. Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.
    Fujinaga S, Sakuraya K, Yamada A, Urushihara Y, Ohtomo Y, Shimizu T.
    Pediatr Nephrol; 2015 Apr; 30(4):687-91. PubMed ID: 25576066
    [Abstract] [Full Text] [Related]

  • 4. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 5. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.
    Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K.
    Pediatr Nephrol; 2011 Oct 01; 26(10):1823-8. PubMed ID: 21556716
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
    Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
    Pediatr Nephrol; 2019 Nov 01; 34(11):2417-2421. PubMed ID: 31435725
    [Abstract] [Full Text] [Related]

  • 7. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
    Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K.
    Pediatr Nephrol; 2007 Jan 01; 22(1):71-6. PubMed ID: 17086405
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
    Clin Nephrol; 2009 Oct 01; 72(4):268-73. PubMed ID: 19825332
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
    Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
    [Abstract] [Full Text] [Related]

  • 10. Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid-resistant nephrotic syndrome.
    Assadi F, Mazaheri M, Sadeghi-Bodj S.
    Pharmacotherapy; 2022 Sep 01; 42(9):690-696. PubMed ID: 35869690
    [Abstract] [Full Text] [Related]

  • 11. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May 01; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A, Hari P, Moudgil A, Jordan SC.
    Am J Kidney Dis; 2003 Dec 01; 42(6):1114-20. PubMed ID: 14655181
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome.
    Gellermann J, Weber L, Pape L, Tönshoff B, Hoyer P, Querfeld U, Gesellschaft für Pädiatrische Nephrologie (GPN).
    J Am Soc Nephrol; 2013 Oct 01; 24(10):1689-97. PubMed ID: 23813218
    [Abstract] [Full Text] [Related]

  • 14. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
    Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K.
    Pediatr Nephrol; 2010 Mar 01; 25(3):539-44. PubMed ID: 20049616
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
    Basu B, Mahapatra TK, Mondal N.
    Pediatrics; 2015 Jul 01; 136(1):e132-9. PubMed ID: 26101364
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.
    Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ.
    Pediatr Nephrol; 2008 Nov 01; 23(11):2013-20. PubMed ID: 18622632
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
    Nephrology (Carlton); 2016 Jan 01; 21(1):21-7. PubMed ID: 26697959
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul 01; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus can induce remission in cyclosporine and mycophenolate mofetil resistant pediatric onset nephrotic syndrome.
    Ahmed HM.
    Iran J Kidney Dis; 2019 Sep 01; 13(5):322-327. PubMed ID: 31705749
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
    Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K, Japanese Study Group of Kidney Disease in Children.
    J Am Soc Nephrol; 2022 Feb 01; 33(2):401-419. PubMed ID: 34880074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.